Ken Fisher
BPMC

Ken Fisher’s Blueprint Medicines BPMC Stock Holding History

Ken Fisher’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,459
Closed -$956K – 1020
2025
Q2 		$956K Sell
7,459
-303,275
-98% -$31.5M ﹤0.01% 698
2025
Q1 		$27.5M Sell
310,734
-12,306
-4% -$1.2M 0.01% 283
2024
Q4 		$28.2M Sell
323,040
-12,310
-4% -$1.13M 0.01% 301
2024
Q3 		$31M Sell
335,350
-815
-0.2% -$81K 0.01% 288
2024
Q2 		$36.2M Buy
336,165
+1,037
+0.3% +$104K 0.02% 262
2024
Q1 		$31.8M Buy
335,128
+8,464
+3% +$726K 0.01% 274
2023
Q4 		$30.1M Sell
326,664
-55,249
-14% -$3.58M 0.02% 276
2023
Q3 		$19.2M Sell
381,913
-417,468
-52% -$22.3M 0.01% 358
2023
Q2 		$50.5M Buy
799,381
+5,310
+0.7% +$289K 0.03% 247
2023
Q1 		$35.7M Sell
794,071
-49,019
-6% -$2.21M 0.02% 289
2022
Q4 		$36.9M Buy
843,090
+117,553
+16% +$5.64M 0.03% 279
2022
Q3 		$47.8M Buy
725,537
+155,026
+27% +$9.96M 0.04% 237
2022
Q2 		$28.8M Buy
570,511
+172,456
+43% +$10.1M 0.02% 276
2022
Q1 		$25.4M Sell
398,055
-2,218
-0.6% -$159K 0.02% 299
2021
Q4 		$42.9M Buy
400,273
+84,615
+27% +$8.85M 0.02% 262
2021
Q3 		$32.5M Buy
+315,658
New +$29.4M 0.02% 269

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ken Fisher's BPMC Position: Q3 2025 in Review

Ken Fisher sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 7,459 shares — an estimated $956K sold.

Ken Fisher first reported a position in BPMC in Q3 2021 and held it in 16 quarters. The position peaked at $50.5M in Q2 2023. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Ken Fisher reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Ken Fisher sold 7,459 Blueprint Medicines shares in Q3 2025, an estimated $956K.
  • Ken Fisher first reported a position in Blueprint Medicines in Q3 2021 and held it in 16 quarters.
  • Ken Fisher's Blueprint Medicines position peaked at $50.5M in Q2 2023.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Fisher Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.